2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 65.812 | 94.565 | 95.399 | 111.804 | 143.942 | 181.834 | 164.273 | 120.332 | 176.960 | 195.653 |
Total Income - EUR | 67.835 | 96.492 | 95.399 | 111.804 | 143.942 | 181.834 | 164.273 | 120.332 | 176.960 | 195.677 |
Total Expenses - EUR | 66.705 | 87.649 | 90.626 | 97.340 | 123.795 | 152.835 | 142.743 | 116.771 | 160.764 | 183.084 |
Gross Profit/Loss - EUR | 1.130 | 8.844 | 4.773 | 14.464 | 20.147 | 28.999 | 21.531 | 3.562 | 16.196 | 12.593 |
Net Profit/Loss - EUR | 931 | 7.411 | 3.819 | 13.346 | 18.708 | 27.181 | 19.979 | 2.382 | 14.462 | 10.634 |
Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Macogenis S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 1.135 | 685 | 319 | 1.477 | 1.140 | 16.217 | 12.149 | 7.630 | 3.402 | 31.504 |
Current Assets | 27.673 | 21.434 | 16.377 | 29.045 | 24.975 | 23.017 | 41.032 | 27.118 | 46.572 | 120.086 |
Inventories | 25.879 | 17.538 | 15.681 | 27.834 | 23.969 | 13.008 | 8.597 | 7.861 | 8.389 | 13.349 |
Receivables | 1.248 | 529 | 0 | 178 | 195 | 239 | 260 | 251 | 535 | 95.281 |
Cash | 546 | 3.367 | 696 | 1.033 | 812 | 9.769 | 32.175 | 19.006 | 37.648 | 11.457 |
Shareholders Funds | -39.156 | -32.072 | -27.926 | -14.107 | 4.859 | 32.030 | 44.997 | 30.422 | 44.978 | 43.649 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 126 | 124 | 121 | 122 | 121 |
Debts | 67.963 | 54.191 | 44.622 | 44.629 | 21.256 | 7.204 | 8.184 | 4.326 | 4.996 | 107.942 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4711 - 4711" | |||||||||
CAEN Financial Year |
4711
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Macogenis S.r.l.